Basnyat B - Search Results

1

Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude.

Droma Y, Hanaoka M, Basnyat B, Arjyal A, Neupane P, Pandit A, Sharma D, Kubo K. Droma Y, et al. Among authors: basnyat b. High Alt Med Biol. 2006 Winter;7(4):312-4. doi: 10.1089/ham.2006.7.312. High Alt Med Biol. 2006. PMID: 17173517

2

Genetic contribution of the endothelial nitric oxide synthase gene to high altitude adaptation in sherpas.

Droma Y, Hanaoka M, Basnyat B, Arjyal A, Neupane P, Pandit A, Sharma D, Miwa N, Ito M, Katsuyama Y, Ota M, Kubo K. Droma Y, et al. Among authors: basnyat b. High Alt Med Biol. 2006 Fall;7(3):209-20. doi: 10.1089/ham.2006.7.209. High Alt Med Biol. 2006. PMID: 16978133

3

Adaptation to high altitude in Sherpas: association with the insertion/deletion polymorphism in the Angiotensin-converting enzyme gene.

Droma Y, Hanaoka M, Basnyat B, Arjyal A, Neupane P, Pandit A, Sharma D, Ito M, Miwa N, Katsuyama Y, Ota M, Kubo K. Droma Y, et al. Among authors: basnyat b. Wilderness Environ Med. 2008 Spring;19(1):22-9. doi: 10.1580/06-WEME-OR-073.1. Wilderness Environ Med. 2008. PMID: 18333655

4

Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas.

Droma Y, Ota M, Hanaoka M, Katsuyama Y, Basnyat B, Neupane P, Arjyal A, Pandit A, Sharma D, Ito M, Kubo K. Droma Y, et al. Among authors: basnyat b. Aviat Space Environ Med. 2008 Nov;79(11):1056-60. doi: 10.3357/asem.2361.2008. Aviat Space Environ Med. 2008. PMID: 18998488

5

Genetic variants in EPAS1 contribute to adaptation to high-altitude hypoxia in Sherpas.

Hanaoka M, Droma Y, Basnyat B, Ito M, Kobayashi N, Katsuyama Y, Kubo K, Ota M. Hanaoka M, et al. Among authors: basnyat b. PLoS One. 2012;7(12):e50566. doi: 10.1371/journal.pone.0050566. Epub 2012 Dec 5. PLoS One. 2012. PMID: 23227185 Free PMC article.

6

Delirium at high altitude.

Basnyat B. Basnyat B. High Alt Med Biol. 2002 Spring;3(1):69-71. doi: 10.1089/152702902753639577. High Alt Med Biol. 2002. PMID: 12006167

7

Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.

Phillips L, Basnyat B, Chang Y, Swenson ER, Harris NS. Phillips L, et al. Among authors: basnyat b. High Alt Med Biol. 2017 Jun;18(2):121-127. doi: 10.1089/ham.2016.0001. Epub 2017 May 16. High Alt Med Biol. 2017. PMID: 28509579

8

Acute medical problems in the Himalayas outside the setting of altitude sickness.

Basnyat B, Cumbo TA, Edelman R. Basnyat B, et al. High Alt Med Biol. 2000 Fall;1(3):167-74. doi: 10.1089/15270290050144163. High Alt Med Biol. 2000. PMID: 11254226 Review.

9

Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.

Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, Kleiman RJ, Loveridge AH, Lundeen EB, Newman SL, Noboa JA, Miegs DP, O'Beirne KA, Philpot KB, Schultz MN, Valente MC, Wiebers MR, Swenson ER. Basnyat B, et al. High Alt Med Biol. 2006 Spring;7(1):17-27. doi: 10.1089/ham.2006.7.17. High Alt Med Biol. 2006. PMID: 16544963 Clinical Trial.

10

The pilgrim at high altitude.

Basnyat B. Basnyat B. High Alt Med Biol. 2006 Fall;7(3):183-4. doi: 10.1089/ham.2006.7.183. High Alt Med Biol. 2006. PMID: 16978128 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

340 results

Search Page